GlobeImmune
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2012 | -13.06M | -108.82K | 25.20K |
|---|---|---|---|
| 2013 | 3.93M | -12.23K | 1.8K |
| 2014 | -10.05M | -166.84K | 21.10M |
| 2015 | -7.12M | 217.96K | 0 |
| 2019 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 |
GBIM Cash Flow Statement (2012 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 0 | 0 | 0 | 0 | 16.81M | 5.92M | 2.00M | 15.15M |
Operating activities | ||||||||
Net income | 0 | 0 | 0 | 0 | -2.76M | -16.26M | 9.47M | -2.01M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 187.33K | 295.16K | 771.28K | 925.47K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 151.81K | 48.87K | 182.55K | 369.18K |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 151.81K | 48.87K | 182.55K | 369.18K |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | -338.51K | -1.16M | -828.88K | 1.64M |
Cash generated by operating activities | 0 | 0 | 0 | 0 | -7.12M | -10.05M | 3.93M | -13.06M |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | -35.74K | -294.2K | -12.23K | -108.82K |
Acquisitions Net | 0 | 0 | 0 | 0 | 253.70K | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 217.96K | -166.84K | -12.23K | -108.82K |
Financing activities | ||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 17.25M | 1.8K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 0 | 0 | 0 | 0 | 0 | 21.10M | 1.8K | 25.20K |
Net Change In Cash | 0 | 0 | 0 | 0 | -6.91M | 10.88M | 3.92M | -13.15M |
Cash at end of period | 0 | 0 | 0 | 0 | 9.90M | 16.81M | 5.92M | 2.00M |